NPI registry status
Active
2026 NPPES data Medical Oncology Physician NPI 1780632828 MD
Verify on CMS → Taral Patel, MD
Medical Oncology Physician in Columbus, Ohio.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 3,815 in Medical Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
838
Medicare Part D claims · 183 beneficiaries · Medical Oncology Physician avg: 689
Generic prescribing
80%
generic claims · 20% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
CMS neutral threshold · no category scores published
Industry payments
$145.2K
319 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Taral Patel, MD carries the neutral CMS MIPS final score of 75/100, assigned where no category was scored - and filed 838 Medicare Part D claims in 2023.
- 75/100
- CMS neutral score · not measured
- 838
- Part D claims, 2023
- 80%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Taral Patel, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
838 ≥ 73rd percentile 73% of 1,370,886 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2023
✓
Board certification likely (heuristic, not verified)
Taral Patel, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Taral Patel, MD?
CMS neutral score, not measuredPrimary specialty
Medical Oncology Physician
Medicare Part D claims
838 22% vs specialty avg
MIPS final score
75/100
Specialty distribution in Ohio
How Medical Oncology Physician compares to other specialties among Ohio providers
MIPS score not measured
CMS assigned a neutral 75/100 threshold
CMS did not publish any Quality, Cost, Promoting Interoperability, or Improvement Activities category score for this clinician. This administrative threshold is not comparable with the national average of clinicians whose MIPS score was measured.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Taral Patel, MD appears in the CMS NPPES registry as a Medical Oncology Physician provider holding MD credentials at 3100 PLAZA PROPERTIES BLVD, Columbus, OH, 43219, with a listed phone of (614) 383-6000. NPI 1780632828 was issued on 05/04/2006.
Medicare Part D records for calendar year 2023 show 838 prescription claims written by this provider, covering 183 Medicare beneficiaries and totaling roughly $2.0 million in drug spend, split 20% brand-name and 80% generic by claim count, with an opioid prescribing rate of 13.1%. On the CMS Merit-based Incentive Payment System, this provider carries a Final Score of 75/100 for the 2023 performance year, but CMS published no Quality, Promoting Interoperability, Improvement Activity or Cost score: this is the neutral performance threshold CMS assigns where nothing was scored, so it is not comparable with clinicians whose score was measured.
Medical Oncology Physician is a narrow specialty nationwide, with 3,815 enrolled providers across 53 states and an average of 689 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1780632828 |
|---|---|
| Specialty | Medical Oncology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 05/04/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
75
Final Score
CMS neutral threshold · not measured
Reporting: Individual
Hospital and facility affiliations
Facilities where Taral Patel, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
American Oncology Partners PA
Columbus, OH
Gahanna Physical Therapy Limited Partnership
Gahanna, OH
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Taral Patel, MD. Source: openpaymentsdata.cms.gov.
Total received
$145.2K
Largest payer
Karyopharm Therapeutics Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Ohio OMB 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~48K Ohio medical licensees in 2023 - they are NOT specific to Taral Patel, MD. To verify Taral Patel, MD's current license status, search the OMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
158
Total board actions, Ohio 2023
Across 154 cases
3.29
Actions per 1,000 licensees
Ohio statewide rate
probation
Most common action type
56 cases
OMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Ohio disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
Taral Patel, MD - brand share 20.0%
Medical Oncology Physician average
20% brand-name claims vs 80% generic, on 838 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
838
Total Claims
$2.0M
Total Drug Cost
183
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,056
- Total Day Supply
- 25,049
- Brand vs Generic
- 20% brand / 80% generic
- Brand Drug Cost
- $2.0M
- Generic Drug Cost
- $50K
- Opioid Claims
- 110 (13.1% rate)
- Antibiotic Claims
- 61
Patient Demographics
- Average Patient Age
- 74.2 years
- Avg HCC Risk Score
- 2.21
- Gender Split
- 48% female / 52% male
- Age Distribution
- <65: 18, 65-74: 71, 75-84: 72, 85+: 22
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Taral Patel, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Prednisone
Prednisone
92 claims
- Oxycodone Hcl
Oxycodone Hcl
74 claims
- Hydroxyurea
Hydroxyurea
58 claims
- Prochlorperazine M… 33
Prochlorperazine Maleate
33 claims
- Azithromycin 29
Azithromycin
29 claims
- Ondansetron Hcl 28
Ondansetron Hcl
28 claims
- Levothyroxine Sodium 23
Levothyroxine Sodium
23 claims
- Jakafi 21
Jakafi
21 claims
| Drug | Claims |
|---|---|
| Prednisone | 92 |
| Oxycodone Hcl | 74 |
| Hydroxyurea | 58 |
| Prochlorperazine Maleate | 33 |
| Azithromycin | 29 |
| Ondansetron Hcl | 28 |
| Levothyroxine Sodium | 23 |
| Jakafi Ruxolitinib Phosphate | 21 |
| Dexamethasone | 20 |
| Xarelto Rivaroxaban | 20 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Medical Oncology Physician Overview
How Taral Patel, MD fits within the Medical Oncology Physician landscape nationally.
3,815
Medical Oncology Physician Providers in US
53
States with Medical Oncology Physician
689
Avg Claims per Provider
Taral Patel, MD's 838 claims are above the specialty average of 689.
Nearby Medical Oncology Physician Providers in Ohio
Other clinicians with the same primary specialty enrolled in Ohio, drawn from the same CMS NPPES roster as Patel.
Dr. Mufti Ahmad
MD
Fairfield Township, OH
Dr. Adnan Al-Khalili
MD
Perrysburg, OH
Dr. Asrar Alahmadi
MD
Columbus, OH
Dr. Adeel Arshad
MD
Columbus, OH
Dr. Robert Baiocchi
M.D.
Columbus, OH
Compare Medical Oncology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Ohio medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Medical Oncology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Ohio
Frequently Asked Questions
What is Taral Patel, MD's specialty? ▼
Taral Patel, MD specializes in Medical Oncology Physician and practices in Columbus, Ohio. Credentials: MD.
How much does Taral Patel, MD prescribe under Medicare Part D? ▼
In 2023, Taral Patel, MD wrote 838 Medicare Part D claims totaling $2.0M in drug costs for 183 beneficiaries.
What is Taral Patel, MD's Medicare quality score? ▼
Taral Patel, MD has a CMS MIPS Final Score of 75/100. CMS published no Quality, Promoting Interoperability, Improvement Activity or Cost score for this clinician, so the final score is the neutral performance threshold CMS assigns rather than a measured result. The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Taral Patel, MD located? ▼
Taral Patel, MD is located at 3100 PLAZA PROPERTIES BLVD, Columbus, OH, 43219. Phone: (614) 383-6000.
What is Taral Patel, MD's NPI number? ▼
Taral Patel, MD's National Provider Identifier (NPI) is 1780632828, issued on 05/04/2006.
Does Taral Patel, MD prescribe more brand-name or generic drugs? ▼
Taral Patel, MD's prescribing is 20% brand-name and 80% generic drugs by claim count, with $2.0M in brand drug costs.
Does Taral Patel, MD prescribe opioids? ▼
Yes, Taral Patel, MD had 110 opioid claims in 2023 with an opioid prescribing rate of 13.1%.
How many Medical Oncology Physician providers are there in the US? ▼
There are 3,815 Medical Oncology Physician providers across 53 states in the US. The average Medical Oncology Physician provider writes 689 Medicare Part D claims per year.
What drugs does Taral Patel, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Taral Patel, MD's most frequently prescribed drugs include Prednisone, Oxycodone Hcl, Hydroxyurea. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Taral Patel, MD accept Medicare? ▼
Taral Patel, MD appears in CMS Medicare data with 838 Part D claims and 183 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Taral Patel, MD's credentials? ▼
Taral Patel, MD's NPI is 1780632828 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.